Cargando…
Inhibition of MC38 colon cancer growth by multicomponent chemoimmunotherapy with anti-IL-10R antibodies, HES-MTX nanoconjugate, depends on application of IL-12, IL-15 or IL-18 secreting dendritic cell vaccines
BACKGROUND: The tumor microenvironment (TME) provides a conducive environment for the growth and survival of tumors. Negative factors present in TME, such as IL-10, may limit the effectiveness of cellular vaccines based on dendritic cells, therefore, it is important to control its effect. The influe...
Autores principales: | Węgierek-Ciura, Katarzyna, Mierzejewska, Jagoda, Szczygieł, Agnieszka, Rossowska, Joanna, Wróblewska, Anna, Świtalska, Marta, Goszczyński, Tomasz M., Szermer-Olearnik, Bożena, Pajtasz-Piasecka, Elżbieta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399586/ https://www.ncbi.nlm.nih.gov/pubmed/37545526 http://dx.doi.org/10.3389/fimmu.2023.1212606 |
Ejemplares similares
-
Combined therapy with methotrexate nanoconjugate and dendritic cells with downregulated IL-10R expression modulates the tumor microenvironment and enhances the systemic anti-tumor immune response in MC38 murine colon carcinoma
por: Szczygieł, Agnieszka, et al.
Publicado: (2023) -
The Beneficial Effect of IL-12 and IL-18 Transduced Dendritic Cells Stimulated with Tumor Antigens on Generation of an Antitumor Response in a Mouse Colon Carcinoma Model
por: Mierzejewska, Jagoda, et al.
Publicado: (2022) -
Immunomodulatory potential of anticancer therapy composed of methotrexate nanoconjugate and dendritic cell-based vaccines in murine colon carcinoma
por: Szczygieł, Agnieszka, et al.
Publicado: (2021) -
Reprogramming the murine colon cancer microenvironment using lentivectors encoding shRNA against IL-10 as a component of a potent DC-based chemoimmunotherapy
por: Rossowska, Joanna, et al.
Publicado: (2018) -
Antitumor Potential of Extracellular Vesicles Released by Genetically Modified Murine Colon Carcinoma Cells With Overexpression of Interleukin-12 and shRNA for TGF-β1
por: Rossowska, Joanna, et al.
Publicado: (2019)